New insights into the biology of osteocalcin

Bone

Volumn 82, Issue , 2016, Pages 42-49

  Zoch, Meredith L ^a   Clemens, Thomas L ^a,b   Riddle, Ryan C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Diabetes; Metabolism; Osteoblast; Osteocalcin

Indexed keywords

ALENDRONIC ACID; DENOSUMAB; G PROTEIN COUPLED RECEPTOR; GLUCOSE; INSULIN; OSTEOCALCIN; PARATHYROID HORMONE; PROTEIN GPRC6A; UNCLASSIFIED DRUG; ZOLEDRONIC ACID; BIOLOGICAL MARKER;

BINDING AFFINITY; BONE MATRIX; BONE MINERALIZATION; COGNITION; DRUG EFFECT; FERTILITY; FRACTURE; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; METABOLIC REGULATION; NONHUMAN; OSTEOPOROSIS; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; ADIPOSE TISSUE; ANIMAL; DIABETES MELLITUS; ENERGY METABOLISM; INSULIN RESISTANCE; METABOLISM; OSTEOBLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; BIOMARKERS; DIABETES MELLITUS; ENERGY METABOLISM; HUMANS; INSULIN RESISTANCE; OSTEOBLASTS; OSTEOCALCIN; SIGNAL TRANSDUCTION;

EID: 84954378583     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.05.046     Document Type: Review

References (110)

1. Clemens T.L., Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 2011, 26:677-680.
2. Karsenty G., Ferron M. The contribution of bone to whole-organism physiology. Nature 2012, 481:314-320.
3. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
4. Bolton J.G., Patel S., Lacey J.H., White S. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005, 16:1955-1962.
5. Nussbaum M., Baird D., Sonnenblick M., Cowan K., Shenker I.R. Short stature in anorexia nervosa patients. J Adolesc Health Care 1985, 6:453-455.
6. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207.
7. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
8. Kajimura D., Lee H.W., Riley K.J., Arteaga-Solis E., Ferron M., Zhou B., et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 2013, 17:901-915.
9. Fulzele K., Riddle R.C., DiGirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142:309-319.
10. Hauschka P.V., Lian J.B., Cole D.E., Gundberg C.M. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989, 69:990-1047.
11. Price P.A., Poser J.W., Raman N. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci U S A 1976, 73:3374-3375.
12. Price P.A., Otsuka A.A., Poser J.W., Kristaponis J., Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A 1976, 73:1447-1451.
13. Price P.A., Urist M.R., Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983, 117:765-771.
14. Price P.A., Williamson M.K. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem 1985, 260:14971-14975.
15. Puchacz E., Lian J.B., Stein G.S., Wozney J., Huebner K., Croce C. Chromosomal localization of the human osteocalcin gene. Endocrinology 1989, 124:2648-2650.
16. Morris D.P., Stevens R.D., Wright D.J., Stafford D.W. Processive post-translational modification. Vitamin K-dependent carboxylation of a peptide substrate. J Biol Chem 1995, 270:30491-30498.
17. Stafford D.W. The vitamin K cycle. J Thromb Haemost 2005, 3:1873-1878.
18. Gundberg C.M., Clough M.E. The osteocalcin propeptide is not secreted in vivo or in vitro. J Bone Miner Res 1992, 7:73-80.
19. Rice J.S., Williamson M.K., Price P.A. Isolation and sequence of the vitamin K-dependent matrix Gla protein from the calcified cartilage of the soupfin shark. J Bone Miner Res 1994, 9:567-576.
20. 2+ on the structure of vitamin K-dependent coagulation factors. Haemostasis 1996, 26(Suppl. 1):45-53.
21. Willems B.A., Vermeer C., Reutelingsperger C.P., Schurgers L.J. The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. Mol Nutr Food Res 2014, 58:1620-1635.
22. Laize V., Martel P., Viegas C.S., Price P.A., Cancela M.L. Evolution of matrix and bone gamma-carboxyglutamic acid proteins in vertebrates. J Biol Chem 2005, 280:26659-26668.
23. Desbois C., Hogue D.A., Karsenty G. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem 1994, 269:1183-1190.
24. Petrucci M., Paquette Y., Leblond F.A., Pichette V., Bonnardeaux A. Evidence that the mouse osteocalcin-related gene does not encode nephrocalcin. Nephron Exp Nephrol 2006, 104:e140-e146.
25. van de Loo P.G., Soute B.A., van Haarlem L.J., Vermeer C. The effect of Gla-containing proteins on the precipitation of insoluble salts. Biochem Biophys Res Commun 1987, 142:113-119.
26. Price P.A., Williamson M.K., Haba T., Dell R.B., Jee W.S. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A 1982, 79:7734-7738.
27. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
28. Boskey A.L., Gadaleta S., Gundberg C., Doty S.B., Ducy P., Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998, 23:187-196.
29. Bronckers A.L., Price P.A., Schrijvers A., Bervoets T.J., Karsenty G. Studies of osteocalcin function in dentin formation in rodent teeth. Eur J Oral Sci 1998, 106:795-807.
30. Murshed M., Schinke T., McKee M.D., Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two Gla-containing proteins. J Cell Biol 2004, 165:625-630.
31. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
32. Ritter N.M., Farach-Carson M.C., Butler W.T. Evidence for the formation of a complex between osteopontin and osteocalcin. J Bone Miner Res 1992, 7:877-885.
33. Hoang Q.Q., Sicheri F., Howard A.J., Yang D.S. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003, 425:977-980.
34. Hauschka P.V., Carr S.A. Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry 1982, 21:2538-2547.
35. Poundarik A.A., Diab T., Sroga G.E., Ural A., Boskey A.L., Gundberg C.M., et al. Dilatational band formation in bone. Proc Natl Acad Sci U S A 2012, 109:19178-19183.
36. Nikel O., Laurencin D., McCallum S.A., Gundberg C.M., Vashishth D. NMR investigation of the role of osteocalcin and osteopontin at the organic-inorganic interface in bone. Langmuir 2013, 29:13873-13882.
37. Furie B., Furie B.C. The molecular basis of blood coagulation. Cell 1988, 53:505-518.
38. Hill H.S., Grams J., Walton R.G., Liu J., Moellering D.R., Garvey W.T. Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm Metab Res 2014, 46:341-347.
39. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008, 105:5266-5270.
40. Ferron M., McKee M.D., Levine R.L., Ducy P., Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2011, 50:568-575.
41. Mizokami A., Yasutake Y., Gao J., Matsuda M., Takahashi I., Takeuchi H., et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS One 2013, 8:e57375.
42. Mizokami A., Yasutake Y., Higashi S., Kawakubo-Yasukochi T., Chishaki S., Takahashi I., et al. Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion. Bone 2014, 69C:68-79.
43. Zhou B., Li H., Liu J., Xu L., Zang W., Wu S., et al. Intermittent injections of osteocalcin reverse autophagic dysfunction and endoplasmic reticulum stress resulting from diet-induced obesity in the vascular tissue via the NFkappaB-p65-dependent mechanism. Cell Cycle 2013, 12:1901-1913.
44. Zhou B., Li H., Xu L., Zang W., Wu S., Sun H. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-kappaB signaling pathway. Endocrinology 2013, 154:1055-1068.
45. Fulzele K., DiGirolamo D.J., Liu Z., Xu J., Messina J.L., Clemens T.L. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007, 282:25649-25658.
46. Ferron M., Wei J., Yoshizawa T., Del Fattore A., DePinho R.A., Teti A., et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010, 142:296-308.
47. Delibegovic M., Zimmer D., Kauffman C., Rak K., Hong E.G., Cho Y.R., et al. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 2009, 58:590-599.
48. Delibegovic M., Bence K.K., Mody N., Hong E.G., Ko H.J., Kim J.K., et al. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol 2007, 27:7727-7734.
49. Engelke J.A., Hale J.E., Suttie J.W., Price P.A. Vitamin K-dependent carboxylase: utilization of decarboxylated bone Gla protein and matrix Gla protein as substrates. Biochim Biophys Acta 1991, 1078:31-34.
50. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
51. Rached M.T., Kode A., Silva B.C., Jung D.Y., Gray S., Ong H., et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 2010, 120:357-368.
52. Kode A., Mosialou I., Silva B.C., Joshi S., Ferron M., Rached M.T., et al. FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis. J Biol Chem 2012, 287:8757-8768.
53. Yoshizawa T., Hinoi E., Jung D.Y., Kajimura D., Ferron M., Seo J., et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest 2009, 119:2807-2817.
54. Yang S., Xu H., Yu S., Cao H., Fan J., Ge C., et al. Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts. J Biol Chem 2011, 286:19149-19158.
55. Riddle R.C., Frey J.L., Tomlinson R.E., Ferron M., Li Y., DiGirolamo D.J., et al. Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis. Mol Cell Biol 2014, 34:1850-1862.
56. Bozec A., Bakiri L., Jimenez M., Schinke T., Amling M., Wagner E.F. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J Cell Biol 2010, 190:1093-1106.
57. Bozec A., Bakiri L., Jimenez M., Rosen E.D., Catala-Lehnen P., Schinke T., et al. Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism. J Cell Sci 2013, 126:5432-5440.
58. Shiba S., Ikeda K., Azuma K., Hasegawa T., Amizuka N., Horie-Inoue K., et al. Gamma-glutamyl carboxylase in osteoblasts regulates glucose metabolism in mice. Biochem Biophys Res Commun 2014, 453:350-355.
59. Ferron M., Lacombe J., Germain A., Oury F., Karsenty G. GGCX and VKORC1 inhibit osteocalcin endocrine functions. J Cell Biol 2015, 208:761-776.
60. Karsenty G., Oury F. Regulation of male fertility by the bone-derived hormone osteocalcin. Mol Cell Endocrinol 2014, 382:521-526.
61. Oury F., Sumara G., Sumara O., Ferron M., Chang H., Smith C.E., et al. Endocrine regulation of male fertility by the skeleton. Cell 2011, 144:796-809.
62. Manolagas S.C., Kousteni S., Jilka R.L. Sex steroids and bone. Recent Prog Horm Res 2002, 57:385-409.
63. Oury F., Ferron M., Huizhen W., Confavreux C., Xu L., Lacombe J., et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 2013, 123:2421-2433.
64. Oury F., Khrimian L., Denny C.A., Gardin A., Chamouni A., Goeden N., et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013, 155:228-241.
65. Patterson-Buckendahl P., Sowinska A., Yee S., Patel D., Pagkalinawan S., Shahid M., et al. Decreased sensory responses in osteocalcin null mutant mice imply neuropeptide function. Cell Mol Neurobiol 2012, 32:879-889.
66. Kuang D., Yao Y., Lam J., Tsushima R.G., Hampson D.R. Cloning and characterization of a family C orphan G-protein coupled receptor. J Neurochem 2005, 93:383-391.
67. Pi M., Faber P., Ekema G., Jackson P.D., Ting A., Wang N., et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 2005, 280:40201-40209.
68. Conigrave A.D., Hampson D.R. Broad-spectrum l-amino acid sensing by class 3G-protein-coupled receptors. Trends Endocrinol Metab 2006, 17:398-407.
69. Conigrave A.D., Hampson D.R. Broad-spectrum amino acid-sensing class C G-protein coupled receptors: molecular mechanisms, physiological significance and options for drug development. Pharmacol Ther 2010, 127:252-260.
70. Clemmensen C., Smajilovic S., Wellendorph P., Brauner-Osborne H. The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function. Br J Pharmacol 2014, 171:1129-1141.
71. Pi M., Chen L., Huang M.Z., Zhu W., Ringhofer B., Luo J., et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One 2008, 3:e3858.
72. Pi M., Wu Y., Quarles L.D. GPRC6A mediates responses to osteocalcin in beta-cells in vitro and pancreas in vivo. J Bone Miner Res 2011, 26:1680-1683.
73. Wei J., Hanna T., Suda N., Karsenty G., Ducy P. Osteocalcin promotes beta-cell proliferation during development and adulthood through Gprc6a. Diabetes 2014, 63:1021-1031.
74. Pi M., Zhang L., Lei S.F., Huang M.Z., Zhu W., Zhang J., et al. Impaired osteoblast function in GPRC6A null mice. J Bone Miner Res 2010, 25:1092-1102.
75. Kindblom J.M., Ohlsson C., Ljunggren O., Karlsson M.K., Tivesten A., Smith U., et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res Off J Am Soc Bone Miner Res 2009, 24:785-791.
76. Yeap B.B., Chubb S.A., Flicker L., McCaul K.A., Ebeling P.R., Beilby J.P., et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010, 163:265-272.
77. Hwang Y.C., Jee J.H., Jeong I.K., Ahn K.J., Chung H.Y., Lee M.K. Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up study. Diabetes Care 2012, 35:1919-1924.
78. Chin K.Y., Ima-Nirwana S., Mohamed I.N., Ahmad F., Ramli E.S., Aminuddin A., et al. Serum osteocalcin is significantly related to indices of obesity and lipid profile in Malaysian men. Int J Med Sci 2014, 11:151-157.
79. Chen X., Wu Y., Liu L., Tian H., Yu X. Osteocalcin is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance. Diabetes Metab Res Rev 2014, 30:476-482.
80. Hwang Y.C., Jeong I.K., Ahn K.J., Chung H.Y. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev 2009, 25:768-772.
81. Sarkar P.D., Choudhury A.B. Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Eur Rev Med Pharmacol Sci 2013, 17:1631-1635.
82. Reinehr T., Roth C.L. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond) 2010, 34:852-858.
83. Kim G.S., Jekal Y., Kim H.S., Im J.A., Park J.Y., Chu S.H. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract 2014, 8:e201-e298.
84. Wang J.W., Tang Q.Y., Ruan H.J., Cai W. Relation between serum osteocalcin levels and body composition in obese children. J Pediatr Gastroenterol Nutr 2014, 58:729-732.
85. Kim Y.S., Nam J.S., Yeo D.W., Kim K.R., Suh S.H., Ahn C.W. The effects of aerobic exercise training on serum osteocalcin, adipocytokines, and insulin resistance on obese young males. Clin Endocrinol (Oxf) 2015, 82:686-694.
86. Levinger I., Jerums G., Stepto N.K., Parker L., Serpiello F.R., McConell G.K., et al. The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res 2014, 29:2571-2576.
87. Levinger I., Scott D., Nicholson G.C., Stuart A.L., Duque G., McCorquodale T., et al. Undercarboxylated osteocalcin, muscle strength and indices of bone health in older women. Bone 2014, 64:8-12.
88. Das S.K., Elbein S.C. The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep 2007, 7:154-164.
89. Xu H., Xiao W., Luo D., Liu Y.M., Zou L., Kuang H.B. Association analysis of genetic polymorphisms and potential interaction of the osteocalcin (BGP) and ER-alpha genes with body mass index (BMI) in premenopausal Chinese women. Acta Pharmacol Sin 2010, 31:455-460.
90. Das S.K., Sharma N.K., Elbein S.C. Analysis of osteocalcin as a candidate gene for type 2 diabetes (T2D) and intermediate traits in Caucasians and African Americans. Dis Markers 2010, 28:281-286.
91. Korostishevsky M., Malkin I., Trofimov S., Pei Y., Deng H.W., Livshits G. Significant association between body composition phenotypes and the osteocalcin genomic region in normative human population. Bone 2012, 51:688-694.
92. Schafer A.L., Sellmeyer D.E., Schwartz A.V., Rosen C.J., Vittinghoff E., Palermo L., et al. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab 2011, 96:E1982-E1989.
93. Schwartz A.V., Schafer A.L., Grey A., Vittinghoff E., Palermo L., Lui L.Y., et al. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res 2013, 28:1348-1354.
94. Caglar G.S., Ozdemir E.D., Kiseli M., Demirtas S., Cengiz S.D. The association of osteocalcin and adiponectin with glucose metabolism in nondiabetic postmenopausal women. Gynecol Obstet Invest 2014, 77:255-260.
95. Liatis S., Sfikakis P.P., Tsiakou A., Stathi C., Terpos E., Katsilambros N., et al. Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals. Diabetes Metab 2014, 40:198-203.
96. Mori K., Emoto M., Motoyama K., Lee E., Yamada S., Morioka T., et al. Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2012, 4:53.
97. Kim S., Lee J.Y., Im J.A., Kim D.W., Lee H.S., Kim S.H., et al. Association between serum osteocalcin and insulin resistance in postmenopausal, but not premenopausal, women in Korea. Menopause 2013, 20:1061-1066.
98. Gower B.A., Pollock N.K., Casazza K., Clemens T.L., Goree L.L., Granger W.M. Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and beta-cell function in overweight adults. J Clin Endocrinol Metab 2013, 98:E1173-E1180.
99. Tabatabaei N., Giguere Y., Forest J.C., Rodd C.J., Kremer R., Weiler H.A. Osteocalcin is higher across pregnancy in Caucasian women with gestational diabetes mellitus. Can J Diabetes 2014, 38:303-313.
100. Kumar R., Binkley N., Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr 2010, 92:1528-1532.
101. Cui R., Su B., Sheng C., Cheng X., Yang P., Bu L., et al. Total osteocalcin in serum predicts testosterone level in male type 2 diabetes mellitus. Int J Clin Exp Med 2014, 7:1145-1149.
102. Kirmani S., Atkinson E.J., Melton L.J., Riggs B.L., Amin S., Khosla S. Relationship of testosterone and osteocalcin levels during growth. J Bone Miner Res 2011, 26:2212-2216.
103. Kanazawa I., Tanaka K., Ogawa N., Yamauchi M., Yamaguchi T., Sugimoto T. Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporos Int 2013, 24:1115-1119.
104. Basu R., Peterson J., Rizza R., Khosla S. Effects of physiological variations in circulating insulin levels on bone turnover in humans. J Clin Endocrinol Metab 2011, 96:1450-1455.
105. Cousin W., Courseaux A., Ladoux A., Dani C., Peraldi P. Cloning of hOST-PTP: the only example of a protein-tyrosine-phosphatase the function of which has been lost between rodent and human. Biochem Biophys Res Commun 2004, 321:259-265.
106. Zee T., Settembre C., Levine R.L., Karsenty G. T-cell protein tyrosine phosphatase regulates bone resorption and whole-body insulin sensitivity through its expression in osteoblasts. Mol Cell Biol 2012, 32:1080-1088.
107. Yoshikawa Y., Kode A., Xu L., Mosialou I., Silva B.C., Ferron M., et al. Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res 2011, 26:2012-2025.
108. Esen E., Chen J., Karner C.M., Okunade A.L., Patterson B.W., Long F. WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab 2013, 17:745-755.
109. Regan J.N., Lim J., Shi Y., Joeng K.S., Arbeit J.M., Shohet R.V., et al. Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation. Proc Natl Acad Sci U S A 2014, 111:8673-8678.
110. Frey J.L., Li Z., Ellis J.M., Zhang Q., Farber C.R., Aja S., et al. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. Mol Cell Biol 2015, 35:1979-1991.